GU Cancers 2020 | Sitravatinib with nivolumab in advanced clear cell RCC

Pavlos Msaouel

Pavlos Msaouel, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the trial (NCT03015740) of sitravatinib combined with nivolumab in patients with advanced clear cell renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter